[1] CONNOR E E,EVOCK-CLOVER C M,WALKER M P,et al.Comparative gut physiology symposium:Comparative physiology of glucagon-like peptide-2:Implications and applications for production and health of ruminants[J].Journal of Animal Science,2015,93(2):492-501. [2] RING L L,NERUP N,JEPPESEN P B,et al.Glucagon like peptide-2 and neoplasia:A systematic review[J].Expert Review of Gastroenterology & Hepatology,2017,12(3):257-264. [3] BRUBAKER P L.Glucagon-like peptide-2 and the regulation of intestinal growth and function[J].Comprehensive Physiology,2018,8(3):1185-1210. [4] 韩斐,江明锋,王刚.胰高血糖素样肽-2及其在畜牧生产中的应用[J].中国畜牧兽医,2019,46(6):1612-1618. HAN F,JIANG M F,WANG G.Glucagon-like peptide-2 and its application in animal production[J].China Animal Husbandry & Veterinary Medicine,2019,46(6):1612-1618.(in Chinese) [5] 陈渝,赵云.胰高血糖素样多肽-2的重组表达及鉴定[J].西南国防医药,2009,19(9):875-878. CHEN Y,ZHAO Y.Expression and identification of recombinant glucagons like peptide-2 prokaryotic[J].Medical Journal of National Defending Forces in Southwest China,2009,19(9):875-878.(in Chinese) [6] HANSEN L,HARE K J,HARTMANN B,et al.Metabolism of glucagon-like peptide-2 in pigs:Role of dipeptidyl peptidase Ⅳ[J].Regulatory Peptides,2007,138(2):126-132. [7] 马先君,杨梅佳,仝爱平.人源抗菌肽AP-57的原核表达与纯化[J].科学技术与工程,2016,16(23):248-252. MA X J,YANG M J,TONG A P.Expression and purification of antimicrobial peptides AP-57[J].Science Technology and Engineering,2016,16(23):248-252.(in Chinese) [8] 任霞,吴忠义,黄丛林,等.拟南芥FT基因原核表达载体的构建、表达和蛋白纯化[J].生物技术通报,2010,3:99-103. REN X,WU Z Y,HUANG C L,et a1.Expression and purification of Arabidopsis FT gene in prokaryotic cells[J].Biotechnology Bulletin,2010,3:99-103.(in Chinese) [9] 潘滨,吴建祥,李桂新,等.烟草曲茎病毒复制相关蛋白基因原核表达条件优化[J].浙江大学报(农业与生命科学版),2007,33(1):24-28. PAN B,WU J X,LI G X,et al.Optimization of prokaryotic expression of Tobacco curly shoot virus replication-associated protein gene[J].Journal of Zhejiang University(Agriculture & Life Sciences) 2007,33(1):24-28.(in Chinese) [10] 张赭,李健,王芸,等.中国对虾细胞色素P450基因CYP4原核表达条件优化[J].海洋科学,2011,35(9):49-55. ZHANG Z,LI J,WANG Y,et al.Optimization of prokaryotic expression of the CYP4 gene of Chinese shrimp (Fenneropenaeus chinensis)[J].Marmine Sicence,201l,35(9):49-55.(in Chinese) [11] 岳盈盈,李鹏,李志会,等.风疹病毒包膜糖蛋白E1的原核表达及条件优化[J].山东医药,2010,50(3):18-19. YUE Y Y,LI P,LI Z H,et a1.Prokaryotic expression and condition optimizing of rubella virus glycoprotein E1[J].Shandong Medical Journal,2010,50(3):18-19.(in Chinese) [12] DRUCKER D J,SHI Q,CRIVICI A,et al.Regulation of the biological activity of glucagon like peptide 2 by dipeptidyl peptidase Ⅵ[J].Nature Biotechnology,1997,15:673-677. [13] OKAWADA M,MARIA H M,TEITELBAUM D H.Use of a DPP-Ⅳ inhibitor leads to accelerated intestinal adaptation in a mouse model of short bowel syndrome[J].Journal of Surgical Research,2010,165(2):212. [14] PETHIYAGODA C L,WELCH D R,FLEMING T P.Dipeptidyl peptidase Ⅳ (DPPIV) inhibits cellular invasion of melanoma cells[J].Clinical & Experimental Metastasis,2000,18(5):391-400. [15] MIETLICKI-BAASE E G,MCGRATH L E,KOCH-LASKOWSKI K,et al.Hindbrain DPP-Ⅳ inhibition improves glycemic control and promotes negative energy balance[J].Physiology & Behavior,2017,173:9-14. [16] PODUST V N,BALAN S,SIM B C,et al.Extension of in vivo half-life of biologically active molecules by XTEN protein polymers[J].Journal of Controlled Release,2016,240:52-66. [17] SCHELLENBERGER V,WANG C W,GEETHING N C,et al.A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner[J].Nature Biotechnology,2009,27(12):1186-1190. [18] ALTERS S E,BRYANT M L,BENJAMIN S,et al.GLP2-2G-XTEN:A Pharmaceutical Protein with improved serum half-life and efficacy in a rat Crohn's disease model[J].PLoS One,2012,7(11):e50630. [19] BENDELE A,SEELY J,RICHEY C,et al.Short communication:Renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins[J].Toxicological Sciences,1998,42(2):152-157. [20] RICHTER A W,AKERBLOM E.Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins[J].International Archives of Allergy and Immunology,1983,70(2):124-131. [21] SRODA K,RYDLEWSKI J,LANGNER M,et al.Repeated injections of PEG-PE liposomes generate anti-PEG antibodies[J].Cellular & Molecular Biology Letters,2005,10(1):37-47. [22] BURNESS C B,MCCORMACK P L.Teduglutide:A review of its use in the treatment of patients with short bowel syndrome[J].Drugs,2013,73(9):935-947. |